Chemotherapeutic prevention studies of prostate cancer

Bob Djavan; Alexandre Zlotta; Claude Schulman; Pierre Teillac; Peter Iversen; Laurent Boccon Gibod; Georg Bartsch; Michael Marberger

doi:10.1097/01.ju.0000108221.63466.7d

Chemotherapeutic prevention studies of prostate cancer

Bob Djavan, Alexandre Zlotta, Claude Schulman, Pierre Teillac, Peter Iversen, Laurent Boccon Gibod, Georg Bartsch, Michael Marberger

29 Citationer (Scopus)

Abstract

Despite advances in the detection and management of prostate cancer, this disease remains a major cause of morbidity and mortality in men. Increasing attention has focused on the role of chemoprevention for prostate cancer, ie the administration of agents that inhibit 1 or more steps in the natural history of prostate carcinogenesis. We review prostate cancer chemoprevention studies in Europe.

Originalsprog	Engelsk
Tidsskrift	Journal of Urology
Vol/bind	171
Udgave nummer	2 Pt 2
Sider (fra-til)	S10-3; discussion S13-4
ISSN	0022-5347
DOI	https://doi.org/10.1097/01.ju.0000108221.63466.7d
Status	Udgivet - 1 feb. 2004

Adgang til dokumentet

10.1097/01.ju.0000108221.63466.7d

Citationsformater

@article{9ec8547d9a2244b9bde6391efb36c008,

title = "Chemotherapeutic prevention studies of prostate cancer",

abstract = "Despite advances in the detection and management of prostate cancer, this disease remains a major cause of morbidity and mortality in men. Increasing attention has focused on the role of chemoprevention for prostate cancer, ie the administration of agents that inhibit 1 or more steps in the natural history of prostate carcinogenesis. We review prostate cancer chemoprevention studies in Europe.",

author = "Bob Djavan and Alexandre Zlotta and Claude Schulman and Pierre Teillac and Peter Iversen and {Boccon Gibod}, Laurent and Georg Bartsch and Michael Marberger",

year = "2004",

month = feb,

day = "1",

doi = "10.1097/01.ju.0000108221.63466.7d",

language = "English",

volume = "171",

pages = "S10--3; discussion S13--4",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc",

number = "2 Pt 2",

}

TY - JOUR

T1 - Chemotherapeutic prevention studies of prostate cancer

AU - Djavan, Bob

AU - Zlotta, Alexandre

AU - Schulman, Claude

AU - Teillac, Pierre

AU - Iversen, Peter

AU - Boccon Gibod, Laurent

AU - Bartsch, Georg

AU - Marberger, Michael

PY - 2004/2/1

Y1 - 2004/2/1

N2 - Despite advances in the detection and management of prostate cancer, this disease remains a major cause of morbidity and mortality in men. Increasing attention has focused on the role of chemoprevention for prostate cancer, ie the administration of agents that inhibit 1 or more steps in the natural history of prostate carcinogenesis. We review prostate cancer chemoprevention studies in Europe.

AB - Despite advances in the detection and management of prostate cancer, this disease remains a major cause of morbidity and mortality in men. Increasing attention has focused on the role of chemoprevention for prostate cancer, ie the administration of agents that inhibit 1 or more steps in the natural history of prostate carcinogenesis. We review prostate cancer chemoprevention studies in Europe.

U2 - 10.1097/01.ju.0000108221.63466.7d

DO - 10.1097/01.ju.0000108221.63466.7d

M3 - Journal article

C2 - 14713746

SN - 0022-5347

VL - 171

SP - S10-3; discussion S13-4

JO - Journal of Urology

JF - Journal of Urology

IS - 2 Pt 2

ER -

Chemotherapeutic prevention studies of prostate cancer

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater